Nathanael S. Gray
Harvard University(US)Nuffield Orthopaedic Centre(GB)University of Oxford(GB)Dana-Farber Cancer Institute(US)Stanford University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Melanoma and MAPK Pathways, RNA modifications and cancer
Most-Cited Works
- → A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles(2017)3,593 cited
- → Targeting cancer with small molecule kinase inhibitors(2008)2,539 cited
- → Systematic identification of genomic markers of drug sensitivity in cancer cells(2012)2,534 cited
- → A Landscape of Pharmacogenomic Interactions in Cancer(2016)2,211 cited
- → An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1(2009)1,792 cited
- → A unifying model for mTORC1-mediated regulation of mRNA translation(2012)1,472 cited